Ozurdex for Retinal Vein Occlusion Study (ORVO Study)
NCT01790685 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2015-04-22
Summary
To measure the pro-permeability factors in the aqueous humor of patients with persistent/recurrent macular edema after an injection of Ozurdex.
Conditions
- Retinal Vein Occlusion
Interventions
- DRUG
-
dexamethasone implant
Sponsors & Collaborators
-
Allergan
collaborator INDUSTRY - lead OTHER
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-02-28
- Primary Completion
- 2014-12-31
- Completion
- 2014-12-31
Countries
- United States
Study Locations
More Related Trials
-
Ozurdex for Treatment of Recalcitrant Diabetic Macular Edema
NCT01571232 ·Status: COMPLETED ·Phase: PHASE2
-
A Safety and Efficacy Study of OZURDEX® in Macular Edema Associated With Branch Retinal Vein Occlusion
NCT01903720 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Ozurdex® Treatment Practice in Patients With Macular Oedema Due to Retinal Vein Occlusion
NCT01618266 ·Status: COMPLETED
-
Dexamethasone Intravitreal Implant After Vitrectomy For Epiretinal Membrane
NCT01410201 ·Status: TERMINATED ·Phase: NA
-
An Observational Study of OZURDEX® in Diabetic Macular Edema (DME)
NCT02188173 ·Status: COMPLETED
-
A 3-Month Clinical Trial to Assess the Safety and Efficacy of the OZURDEX® Intraocular Implant in Patients With Diabetes Mellitus
NCT01673191 ·Status: COMPLETED ·Phase: PHASE2
-
Patient Preferences on Same-day Bilateral Intravitreal Dexamethasone Injections
NCT06894017 ·Status: RECRUITING
-
Efficacy of Ozurdex® in the Treatment of Diabetic Macular Edema (DME)
NCT03003416 ·Status: COMPLETED
-
Ozurdex for Diabetic Macular Edema Treated With Pars Plana vitrEctomy and Membrane RemovAl (OPERA Study)
NCT01613716 ·Status: COMPLETED ·Phase: PHASE4
-
Retrospective Trial on the Efficacy and Safety of Intravitreal Ozurdex in Patients With Diabetic Macular Edema.
NCT02121197 ·Status: COMPLETED
-
A Study to Evaluate the Effectiveness and Safety of OZURDEX® in Patients With Diabetic Macular Edema But Never Treated
NCT03953807 ·Status: COMPLETED ·Phase: PHASE4
-
Diabetic Macular Edema Treated With Ozurdex (DMEO)
NCT01951066 ·Status: COMPLETED ·Phase: PHASE2
-
Ozurdex in Suboptimal Diabetic Macular Edema Patients
NCT04856397 ·Status: UNKNOWN ·Phase: NA
-
Chart Review: Drug Utilization Study in Participants Who Received Ozurdex™ (Dexamethasone Intravitreal Implant) 0.7 mg Injections for Visual Impairment Due to Diabetic Macular Edema (DME)
NCT03889444 ·Status: COMPLETED
-
The Effects of Intravitreal Ozurdex Implant in DME
NCT03475407 ·Status: UNKNOWN ·Phase: PHASE4
-
Safety and Efficacy of Dexamethasone (OZURDEX®) Intravitreal Implant in Korea
NCT01976650 ·Status: COMPLETED
-
Effect of Dexamethasone Implant in Hard Exudate Complicated With Diabetic Macular Edema
NCT02399657 ·Status: UNKNOWN ·Phase: PHASE4
-
Steroid vs. Anti-vascular Endothelial Growth Factor for Diabetic Macular Edema Prior to Phacoemulsification
NCT03832179 ·Status: COMPLETED ·Phase: PHASE4
-
A Real-world Study to Assess Safety of OZURDEX® (Dexamethasone Intravitreal Implant) in Adult Participants With Diabetic Macular Edema in China
NCT06548568 ·Status: ACTIVE_NOT_RECRUITING
-
Safety and Effectiveness of Ozurdex Steroid Implants for DME After Vitrectomy Surgery
NCT01788475 ·Status: TERMINATED ·Phase: NA
-
Study of OZURDEX® in the Treatment of Diabetic Macular Oedema (DME) in Australia - The AUSSIEDEX Study
NCT02731911 ·Status: COMPLETED
-
Effect of Intravitreal Long Acting Dexamethasone Implant, Ozurdex in Patients With Diabetic Macular Edema
NCT01698749 ·Status: COMPLETED ·Phase: NA
-
Multicentre Randomised Clinical Trial Comparing Fixed vs Pro re Nata (PRN) Dosing of 700 μg Dexamethasone
NCT01892163 ·Status: COMPLETED ·Phase: PHASE3
-
Increase in Capillary Plexus Density Level Following the Use of Ozurdex for the Treatment of DME
NCT04038125 ·Status: UNKNOWN ·Phase: PHASE4
-
Dexamethasone Implant for Retinal Detachment in Uveal Melanoma
NCT04082962 ·Status: COMPLETED ·Phase: PHASE1